Real-time enrollment status for this head and neck squamous cell carcinoma (hnscc) - recurrent/metastatic (r/m) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:16 PM UTC
| NCT Number | NCT07423078 |
| Recruiting Status | Recruiting |
| Condition | Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) |
| Phase | Clinical Trial |
| Target Enrollment | 87 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Matthew Spector |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 13, 2026: Clinical trial NCT07423078 is currently recruiting participants. This clinical trial study for head and neck squamous cell carcinoma (hnscc) - recurrent/metastatic (r/m) is actively seeking new participants at 1 location across the United States. The study is sponsored by Matthew Spector. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07423078 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07423078 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.